c-Myc inhibition decreases CIP2A and reduces BCR-ABL1 tyrosine kinase activity in chronic myeloid leukemia.
Affiliation
University of Liverpool, Royal Liverpool University hospitalPublication Date
2015-05-01
Metadata
Show full item recordAbstract
NACitation
Lucas, C., Harris, R., Giannoudis, A., & Clark, R. (2015). c-myc inhibition decreases CIP2A and reduces BCR-ABL1 tyrosine kinase activity in chronic myeloid leukemia. Haematologica, 100(5), e179-e182Publisher
Ferrata Storti FoundationJournal
HaematologicaAdditional Links
http://www.haematologica.org/content/100/5/e179.article-infoType
ArticleLanguage
enISSN
0390-6078EISSN
1592-8721ae974a485f413a2113503eed53cd6c53
10.3324/haematol.2014.115691
Scopus Count
Collections
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-nd/4.0/